Summary of Shareholders Equity Warrants Outstanding (Details) - $ / shares |
6 Months Ended | 12 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2020 |
Dec. 31, 2019 |
|||||||||
| Equity [Abstract] | ||||||||||
| Shares Outstanding, beginning | 5,397 | [1] | 5,799 | |||||||
| Shares Issued | ||||||||||
| Shares Exercised | (2,576) | [2] | (402) | |||||||
| Shares Tendered | ||||||||||
| Shares Expired | (1,493) | |||||||||
| Shares Outstanding, ending | 1,328 | [3] | 5,397 | [1] | ||||||
| Weighted average of exercise price for outstanding warrants | $ 0.55 | $ 0.62 | ||||||||
| Number of warrant common stock converted | 1,737,400 | |||||||||
| ||||||||||
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments tendered. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non-options equity instruments weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|